allergy and intolerances project
Post on 24-Feb-2016
37 Views
Preview:
DESCRIPTION
TRANSCRIPT
© 2012 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International. Reg. U.S. TM Office.
Allergy and Intolerances Project
HL7 WG Meeting 2013Cambridge
Patient Care WGSeptember 25, 2013 Q4
© 2012 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International. Reg. U.S. TM Office. 2
Agenda
Update on Domain Analysis Model Update on Clinical Statement DSTU Clinical Statement ballot reconciliation Planning for conference calls
01/01/2011
© 2012 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International. Reg. U.S. TM Office. 3
Domain Analysis Model Balloted in January and May 2013 Ballot for Informative currently open until October 7th! Use cases:
Observed new allergy New reported intolerance Allergic reaction to a device Misattribution of an allergy Known allergy is resolved Unable to determine triggering agent No known history of allergy or intolerances Allergy and intolerance information not asked Patient documents allergy in a PHR Reconciliation of allergy/intolerance list
01/01/2011
© 2012 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International. Reg. U.S. TM Office. 4
Allergy and Intolerance Information Model
01/01/2011
© 2012 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International. Reg. U.S. TM Office. 5
DAM – Outstanding Issues Ballot reconciliation Publishing of DAM as informative Preferences - next steps required? FHIR resource – any outstanding issues? Cross-walk with other projects?
01/01/2011
© 2012 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International. Reg. U.S. TM Office. 6
Phase Two – Clinical Models Just completed DSTU ballot cycle
29 ballot comments Allergy vs. intolerance Criticality vs. severity
01/01/2011
© 2012 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International. Reg. U.S. TM Office. 7
Conference Calls Next steps
Testing models – need additional testers Existing - adverse reaction content in V3? Reconciliation Terminology requirements
NDFRT – PharmacyHIT Other substances – resources available?
• Va/NHS/SNOMED/RxNorm Templates for C-CDA for allergy list and adverse reaction Preferences – through OO – ballot in January
OO has the allergy use cases as well as diet order use cases Harmonize with care plan preference component
• PC WG will need to provide tx preferences, end-of-life, advanced directives
01/01/2011
© 2012 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International. Reg. U.S. TM Office. 8
Ballot reconciliation
01/01/2011
© 2012 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International. Reg. U.S. TM Office. 9 01/01/2011
top related